Abstract

Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease. To identify additional genetic factors, we analyzed exome sequences in a large cohort of Chinese ALS patients and found a homozygous variant (p.L700P) in PCDHA9 in three unrelated patients. We generated Pcdhα9 mutant mice harboring either orthologous point mutation or deletion mutation. These mice develop progressive spinal motor loss, muscle atrophy, and structural/functional abnormalities of the neuromuscular junction, leading to paralysis and early lethality. TDP-43 pathology is detected in the spinal motor neurons of aged mutant mice. Mechanistically, we demonstrate that Pcdha9 mutation causes aberrant activation of FAK and PYK2 in aging spinal cord, and dramatically reduced NKA-α1 expression in motor neurons. Our single nucleus multi-omics analysis reveals disturbed signaling involved in cell adhesion, ion transport, synapse organization, and neuronal survival in aged mutant mice. Together, our results present PCDHA9 as a potential ALS gene and provide insights into its pathogenesis.

Genetic mutations are found in only 15% of sporadic ALS. Here, authors identify PCDHA9 as a candidate ALS gene and elucidate detailed underlying pathogenesis using mice with Pcdhα9 mutations that develop typical ALS phenotype and hallmark pathology.

Details

Title
PCDHA9 as a candidate gene for amyotrophic lateral sclerosis
Author
Zhong, Jie 1 ; Wang, Chaodong 2   VIAFID ORCID Logo  ; Zhang, Dan 1   VIAFID ORCID Logo  ; Yao, Xiaoli 3   VIAFID ORCID Logo  ; Zhao, Quanzhen 4 ; Huang, Xusheng 5 ; Lin, Feng 6 ; Xue, Chun 1   VIAFID ORCID Logo  ; Wang, Yaqing 1   VIAFID ORCID Logo  ; He, Ruojie 3 ; Li, Xu-Ying 2 ; Li, Qibin 7 ; Wang, Mingbang 8   VIAFID ORCID Logo  ; Zhao, Shaoli 1 ; Afridi, Shabbir Khan 1   VIAFID ORCID Logo  ; Zhou, Wenhao 8   VIAFID ORCID Logo  ; Wang, Zhanjun 2 ; Xu, Yanming 4   VIAFID ORCID Logo  ; Xu, Zhiheng 1   VIAFID ORCID Logo 

 Chinese Academy of Sciences, State Key Laboratory of Molecular Developmental Biology, Institute of Genetics and Developmental Biology, Beijing, China (GRID:grid.9227.e) (ISNI:0000000119573309); University of Chinese Academy of Sciences, Beijing, China (GRID:grid.410726.6) (ISNI:0000 0004 1797 8419) 
 Capital Medical University, National Clinical Research Center for Geriatric Disease, Department of Neurology, Xuanwu Hospital, Beijing, China (GRID:grid.24696.3f) (ISNI:0000 0004 0369 153X) 
 Sun Yat-sen University, Department of Neurology, The First Affiliated Hospital, Guangzhou, China (GRID:grid.12981.33) (ISNI:0000 0001 2360 039X) 
 Sichuan University, Department of Neurology, West China Hospital, Chengdu, China (GRID:grid.13291.38) (ISNI:0000 0001 0807 1581) 
 The First Medical Center, Chinese PLA General Hospital, Department of Neurology, Beijing, China (GRID:grid.414252.4) (ISNI:0000 0004 1761 8894) 
 Fujian Medical University Union Hospital, Department of Neurology, Fuzhou, China (GRID:grid.411176.4) (ISNI:0000 0004 1758 0478) 
 Shenzhen Clabee Biotechnology Incorporation, Shenzhen, China (GRID:grid.24696.3f) 
 National Center for Children’s Health, Shanghai Key Laboratory of Birth Defects, Division of Neonatology, Children’s Hospital of Fudan University, Shanghai, China (GRID:grid.411333.7) (ISNI:0000 0004 0407 2968) 
Pages
2189
Publication year
2024
Publication date
2024
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2955123199
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.